These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3954816)

  • 1. The influence of diuretics on the excretion and metabolism of doping agents. II. Phentermine.
    Delbeke FT; Debackere M
    Arzneimittelforschung; 1986; 36(1):134-7. PubMed ID: 3954816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine.
    Delbeke FT; Debackere M
    Arzneimittelforschung; 1986 Sep; 36(9):1413-6. PubMed ID: 3790195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of diuretics on the excretion and metabolism of doping agents--V. Dimefline.
    Delbeke FT; Debackere M
    J Pharm Biomed Anal; 1991; 9(1):23-8. PubMed ID: 2043718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of diuretics on the excretion and metabolism of doping agents. Part IV--Caffeine.
    Delbeke FT; Debackere M
    Biopharm Drug Dispos; 1988; 9(2):137-45. PubMed ID: 3370304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of diuretics on the excretion and metabolism of doping agents - I. Mephentermine.
    Delbeke FT; Debackere M
    J Pharm Biomed Anal; 1985; 3(2):141-8. PubMed ID: 16867696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic and pharmacokinetic study of a slow-release formulation of furosemide in man.
    Ebihara A; Tawara K; Oka T
    Arzneimittelforschung; 1983; 33(1):163-6. PubMed ID: 6681970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of diuretics on the excretion and metabolism of doping agents: Part VI. Pseudoephedrine.
    Delbeke FT; Debackere M
    Biopharm Drug Dispos; 1991; 12(1):37-48. PubMed ID: 2039811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
    Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
    Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetics of phentermine extended-release capsules.
    Groenewoud G; Schall R; Hundt HK; Müller FO; van Dyk M
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):368-72. PubMed ID: 8225680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diuretics on calcium excretion and Ca2+-activated ATPase in rat kidney.
    Gemba M; Nishimura K
    Jpn J Pharmacol; 1977 Apr; 27(2):205-11. PubMed ID: 142165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of ischemic injury to the isolated perfused rat liver by loop diuretics.
    Fiegen RJ; Rauen U; Hartmann M; Decking UK; de Groot H
    Hepatology; 1997 Jun; 25(6):1425-31. PubMed ID: 9185763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bumetanide, a new loop diuretic.
    Carrière S; Dandavino R
    Clin Pharmacol Ther; 1976 Oct; 20(4):424-38. PubMed ID: 788989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple-units controlled-release formulation.
    Skinhøj A; Bechgaard H; Chasseaud LF; Brodie RR; Sharman JM; Taylor T; Hunter JO
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):557-61. PubMed ID: 6511132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion complexation of furosemide in cyclodextrins. Part 2: Implication on bioavailability.
    Ammar HO; Ghorab M; Emara LH; el-Nahhas SA; Makram TS
    Pharmazie; 1999 Mar; 54(3):207-10. PubMed ID: 10192107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of furosemide and bumetanide on cerebrospinal fluid formation.
    Vogh BP; Langham MR
    Brain Res; 1981 Sep; 221(1):171-83. PubMed ID: 6791768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic activity of the aqueous extracts of Carum carvi and Tanacetum vulgare in normal rats.
    Lahlou S; Tahraoui A; Israili Z; Lyoussi B
    J Ethnopharmacol; 2007 Apr; 110(3):458-63. PubMed ID: 17113735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and diuretic effect after administration of retarded capsules of bumetanide in human subjects.
    Yagi N; Kiuchi T; Satoh H; Ishikawa Y; Takada M; Sekikawa H
    Biol Pharm Bull; 1999 Mar; 22(3):275-80. PubMed ID: 10220284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and metabolism of fencamfamine and the influence of acetazolamide on its urinary excretion.
    Delbeke FT; Debackere M
    Biopharm Drug Dispos; 1981; 2(1):17-30. PubMed ID: 7236868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.